Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an emerging concept of oral‐liver axis

R Kuraji, S Sekino, Y Kapila, Y Numabe - Periodontology 2000, 2021 - Wiley Online Library
Periodontal disease, a chronic inflammatory disease of the periodontal tissues, is not only a
major cause of tooth loss, but it is also known to exacerbate/be associated with various …

A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics

MA Ozma, SR Moaddab, H Hosseini… - Critical reviews in …, 2024 - Taylor & Francis
Antibiotic resistance is a significant public health issue, causing illnesses that were once
easily treatable with antibiotics to develop into dangerous infections, leading to substantial …

Probiotics, including nisin‐based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases

T Nguyen, H Brody, GH Lin, H Rangé… - Periodontology …, 2020 - Wiley Online Library
The effects of probiotic supplementation on systemic health and gastrointestinal diseases
have been investigated in numerous studies. The aim of this review is to provide an …

Molecular mechanism of microbiota metabolites in preterm birth: pathological and therapeutic insights

AZ Ansari, S Bose, Y You, S Park, Y Kim - International Journal of …, 2021 - mdpi.com
Preterm birth (PTB) refers to the birth of infants before 37 weeks of gestation and is a
challenging issue worldwide. Evidence reveals that PTB is a multifactorial dysregulation …

[HTML][HTML] Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis

R Kuraji, T Shiba, TS Dong, Y Numabe… - World journal of …, 2023 - ncbi.nlm.nih.gov
A growing body of evidence from multiple areas proposes that periodontal disease,
accompanied by oral inflammation and pathological changes in the microbiome, induces gut …

Lipolytic Postbiotic from Lactobacillus paracasei Manages Metabolic Syndrome in Albino Wistar Rats

A Osman, N El-Gazzar, TN Almanaa, A El-Hadary… - Molecules, 2021 - mdpi.com
The current study investigates the capacity of a lipolytic Lactobacillus paracasei postbiotic as
a possible regulator for lipid metabolism by targeting metabolic syndrome as a possibly …

The impacts of herbal medicines and natural products on regulating the hepatic lipid metabolism

S Li, Y Xu, W Guo, F Chen, C Zhang, HY Tan… - Frontiers in …, 2020 - frontiersin.org
The dysregulation of hepatic lipid metabolism is one of the hallmarks in many liver diseases
including alcoholic liver diseases (ALD) and non-alcoholic fatty liver diseases (NAFLD) …

Beyond the scavenging of reactive oxygen species (ROS): direct effect of cerium oxide nanoparticles in reducing fatty acids content in an in vitro model of …

M Parra-Robert, E Casals, N Massana, M Zeng… - Biomolecules, 2019 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic accumulation of lipids.
Antisteatotic effects of cerium oxide nanoparticles (CeO2NPs) have recently been shown in …

[HTML][HTML] Massa medicata fermentata, a functional food for improving the metabolic profile via prominent anti-oxidative and anti-inflammatory effects

KM Jung, GR Yu, DH Kim, DW Lim, WH Park - Antioxidants, 2024 - mdpi.com
Massa Medicata Fermentata (MMF) is a naturally fermented product used to treat indigestion
and increase stomach activity in traditional medicine. This study examined the ability of the …

Cynanchum atratum Alleviates Non-Alcoholic Fatty Liver by Balancing Lipogenesis and Fatty Acid Oxidation in a High-Fat, High-Fructose Diet Mice Model

JH Wang, SJ Hwang, DW Lim, CG Son - Cells, 2021 - mdpi.com
Cynanchum atratum, a medicinal herb, is traditionally used as an antidote, diuretic, and
antipyretic in eastern Asia. The current study aimed to investigate the anti-fatty liver capacity …